General Characteristics and Indications
Immunostimulating agents represent a vast group of pharmacological preparations. Their main therapeutic objective is to activate the body's defense mechanisms. Notably, the specific target of these drugs is the immune system itself, rather than the hypothalamo-pituitary axis, the reticuloendothelial system, or the complement system in isolation.
In clinical practice, three primary categories of indications for immunostimulants are distinguished:
- Immunodeficiency states of various etiologies.
- Chronic persistent infections where the patient's immune system is unable to clear the infectious agent independently.
- Certain oncological diseases (used as part of combination therapy to support the immune response).
Colony-Stimulating Factors and Interleukins
Cytokine preparations constitute a significant portion of immunostimulants. They are actively used for targeted regulation of immune processes.
The group of colony-stimulating factors (CSFs) includes the following agents:
- Molgramostim.
- Filgrastim and its derivative pegfilgrastim.
- Lenograstim.
- Sargramostim.
Another important cytokine subgroup comprises interleukin preparations. This category includes drugs such as aldesleukin, betaleukin, and oprelvekin.
Interferon Preparations
Interferons are classified into three major groups based on the type of active substance (alpha, beta, or gamma).
- Interferons alpha: include interferon alfa, interferon alfa-2a, interferon alfa-2b, and interferon alfa-n1.
- Interferons beta: represented by interferon beta-1a and interferon beta-1b.
- Interferons gamma: the primary representative in this classification is interferon gamma.
Classification of Other Agents by Origin
The group of "other immunostimulants" is subdivided into several categories depending on the source of the active substance:
- Endogenous polypeptides (and their analogs). These include thymalin and immunofan.
- Synthetic agents. Notable representatives include levamisole and azoximer bromide (widely known as polyoxidonium).
- Microbial-derived preparations (and their analogs). These include agents created from bacterial components, such as Broncho-Vaxom, Ribomunyl, and prodigiosan.
- Interferon inducers. Unlike exogenous interferon preparations, these agents stimulate the patient's cells to produce their own endogenous interferon. Examples include tylron and meglumine acridoneacetate.
- Miscellaneous immunostimulants. This mixed group includes herbal and other preparations, such as echinacea extracts, galavit, ersibol, and estifan.